Amazon faces E.U. antitrust scrutiny over the current e-commerce use of merchant data.
Olivia London

2019-08-16 17:37:00 Fri ET

Amazon faces E.U. antitrust scrutiny over the current e-commerce use of merchant data. The European Commission probes into whether Amazon uses key third-party seller data to promote its products to the detriment of other retailers. This antitrust investigation serves as an incremental step toward better characterizing Amazon e-commerce business practices. The current preliminary inquiry helps reveal how tech titans such as Amazon may use customer information to reinforce their market power.

The core concern arises from negative feedback from European third-party sellers, retailers, and manufacturers that Amazon has been trying to abuse its dual role as a direct e-commerce competitor and also as an online marketplace for merchants. Under the current Amazon terms of service for Europe, third-party sellers and other merchants grant Amazon royalty-free rights to use their own product information, content, technology, and trademark design. European Competition Commissioner Margrethe Vestager argues that global e-commerce platforms should not eliminate consumer benefits such as better product prices and broader choices through anti-competitive business practices. E.U. regulators can impose fines up to 10%-15% of global sales; however, some antitrust experts indicate the essential need for the European Commission to establish a new precedent of key industry standards and best practices for cross-border e-commerce.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More
Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits.
Joseph Corr

2019-05-23 10:33:00 Thursday ET

Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits.

Berkeley professor and economist Barry Eichengreen reconciles the nominal and real interest rates to argue in favor of greater fiscal deficits. French econo

+See More
What are the primary pros and cons of free trade or fair trade in the current Sino-American quagmire?
Jonah Whanau

2018-05-02 06:32:00 Wednesday ET

What are the primary pros and cons of free trade or fair trade in the current Sino-American quagmire?

What are the primary pros and cons of free trade or fair trade in the current Sino-American quagmire? Free trade means allowing goods and services to move a

+See More
Former White House chief economic advisor Gary Cohn points out that there is no instant cure for the Sino-U.S. trade dilemma.
Rose Prince

2018-11-23 09:39:00 Friday ET

Former White House chief economic advisor Gary Cohn points out that there is no instant cure for the Sino-U.S. trade dilemma.

Former White House chief economic advisor Gary Cohn points out that there is no instant cure for the Sino-U.S. trade dilemma. After the U.S. midterm electio

+See More
Federal Reserve confirms that all of the 34 major banks pass their annual CCAR macro stress tests.
Apple Boston

2017-05-31 06:36:00 Wednesday ET

Federal Reserve confirms that all of the 34 major banks pass their annual CCAR macro stress tests.

The Federal Reserve rubber-stamps the positive conclusion that all of the 34 major banks pass their annual CCAR macro stress tests for the first time since

+See More
Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.
Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More
IMF chief economist Gita Gopinath predicts no global recession with key downside risks at this delicate moment.
Charlene Vos

2019-04-29 08:35:00 Monday ET

IMF chief economist Gita Gopinath predicts no global recession with key downside risks at this delicate moment.

IMF chief economist Gita Gopinath predicts no global recession with key downside risks at this delicate moment. First, trade tensions remain one of the key

+See More